Influx Healthtech Limited - IPO
SMEInflux Healthtech IPO Details
Influx Healthtech IPO Lot Size
| Application | Lots | Shares | Amount |
|---|---|---|---|
To be announced | |||
Influx Healthtech IPO Reservation
Promoter Holding
Documents
Influx Healthtech IPO Valuations
Influx Healthtech Limited Financial Information
| Period Ended | 30 Nov 2024 | 31 Mar 2024 | 31 Mar 2023 | 31 Mar 2022 |
| Assets | 56.97 | 41.1 | 28.3 | 17.59 |
| Revenue | 63.29 | 100.1 | 76.07 | 59.2 |
| Profit After Tax | 8.05 | 11.22 | 7.2 | 4.43 |
| Net Worth | 30.92 | 22.87 | 11.65 | 4.46 |
| Reserves and Surplus | 12.77 | 22.85 | 11.63 | 4.43 |
| Total Borrowing | 0.27 | 0.29 | 0.75 | 0.57 |
| Amount in ₹ Crore | ||||
About Influx Healthtech IPO
Incorporated in September 2020, Influx Healthtech Limited is a healthcare-focused company specialising in contract manufacturing. The company is a reliable CDMO, providing specialized services to clients in multiple industries.
The company has three manufacturing facilities in Thane, Maharashtra, each covering an area of 9,676 square feet, 13,000 square feet, and 14,000 square feet, respectively.
The product portfolio of the company consists of the following
- Tablets, Capsules, and Powders
- Liquid Orals and Softgels
- Lozenges, Jellies, and Gummies
- Oral Dispersible Films (ODFs)
- Effervescent Tablets and Liquid-Fill Capsules
- Candies and Gym/Sports Supplements
- Skin Care and Body Care Products
- Hair Care and Beard Care Solutions
- Face Masks and Soaps.
- Ayurvedic / Herbal formulations
- Veterinary Feed Supplements
- Homecare solutions
The Company aids Nutraceutical and Cosmetic firms with product development and manufacturing. It offers end-to-end services, including development, production, and regulatory support, enabling clients to focus on formulation and commercialization.
As of March 31, 2024, key clients include Bling Brands, Evoq Ventures, HSHS Nutraceuticals, Bruder Life Science, and Bigflex Lifescience.
Strength Of Influx Healthtech IPO
Risk Of Influx Healthtech IPO
Objectives Influx Healthtech IPO
- Funding capital expenditure requirements for setting up of manufacturing facility for the Nutraceutical Division.
- Funding capital expenditure requirements for setting up of manufacturing facility for Veterinary Food Division.
- Purchase of Machineries for Homecare and Cosmetic Division.
- General Corporate Purposes.
Company Contact Details
Influx Healthtech Limited
109, Ghanshyam Enclave Premises Co-op
Soc Plot No. 856, Laljipada
Kandivali West, Mumbai - 400067
Phone: +91 7045997809
Email: cs@influxhealthtech.com
Website: https://influxhealthtech.com/
Registrar Contact Details
Lead Mangers
Rarever Financial Advisors Pvt. Ltd. Pvt. Ltd.
Market Maker
To be announced